封面
市场调查报告书
商品编码
1622498

皮肤助推剂市场规模、份额、成长分析、按类型、性别、最终用途、按地区 - 行业预测,2025-2032 年

Skin Boosters Market Size, Share, Growth Analysis, By Type (Mesotherapy, Micro-Needle), By Gender (Female, Male), By End-Use, By Region - Industry Forecast 2025-2032

出版日期: | 出版商: SkyQuest | 英文 198 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2023年Skin Booster的市场规模为10,748.2亿美元,将从2024年的11,726.3亿美元增长到2032年的23,537.5亿美元,在预测期内(2025-2032年)预计复合年增长率为9.1%。 。

由于消费者对护肤和美容的兴趣日益浓厚,全球皮肤促进剂市场正处于强劲成长轨道。这些基于透明质酸的微创美容填充剂可满足非手术程序的需求,以最短的停机时间提供自然的效果。随着皮肤病发病率的上升,老龄化人口的迅速增加,寻求预防与老龄化相关的衰退正在推动巨大的市场兴趣。技术的进步导致了创新配方和更好的给药方法的开发,提高了治疗的功效和安全性。北美目前在高消费支出和强大的医疗基础设施的支持下主导市场,但由于可支配收入的增加和美容标准的变化,亚太地区正在迅速崛起。儘管面临监管审查和成本障碍等挑战,但在持续的技术创新和不断扩大的客户群的支持下,皮肤促进剂市场预计将继续增长。

目录

介绍

  • 研究目的
  • 调查范围
  • 定义

调查方法

  • 资讯采购
  • 二手资料和主要资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 按细分市场的机会分析

市场动态及展望

  • 市场概况
  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 抑制因素和挑战
  • 波特的分析

主要市场考察

  • 关键成功因素
  • 竞争程度
  • 主要投资机会
  • 市场生态系统
  • 市场吸引力指数(2024年)
  • PESTEL分析
  • 总体经济指标
  • 价值链分析
  • 价格分析
  • 监管环境
  • Start-Ups分析
  • 专利分析
  • 贸易分析

皮肤促进剂市场规模:按类型和复合年增长率(2025-2032)

  • 市场概况
  • 美塑疗法
    • 玻尿酸
    • 维他命
    • 矿物
  • 微型针
    • 皮肤填充剂
    • 富血小板血浆 (PRP)

皮肤促进剂市场规模:性别与复合年增长率(2025-2032)

  • 市场概况
  • 女士
  • 男性

皮肤促进剂市场规模:依最终用途和复合年增长率(2025-2032)

  • 市场概况
  • 皮肤科诊所
  • 梅迪斯帕

皮肤促进剂市场规模:按地区和复合年增长率(2025-2032)

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲国家地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东/非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东/非洲

竞争资讯

  • 前5名企业对比
  • 主要企业市场定位(2024年)
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市场占有率分析(2024年)
  • 主要企业简介
    • 公司简介
    • 产品系列分析
    • 按细分市场分類的份额分析
    • 收益与前一年同期比较(2022-2024)

主要企业简介

  • Galderma SA(Switzerland)
  • Merz Aesthetics(Germany)
  • Bloomage Biotechnology Corporation Limited(China)
  • Teoxane Laboratories(Switzerland)
  • Filorga(France)
  • Professional Derma SA(Switzerland)
  • IBSA-Institute Biochemical SA(Switzerland)
  • Revance Therapeutics, Inc.(USA)
  • Suneva Medical, Inc.(USA)
  • Anika Therapeutics, Inc.(USA)
  • Prollenium Medical Technologies Inc.(Canada)
  • Revitrane(South Korea)
  • Caregen Co., Ltd.(South Korea)
  • Hugel, Inc.(South Korea)
  • Daewoong Pharmaceutical Co., Ltd.(South Korea)
  • LG Chem Ltd.(South Korea)
  • Hyundai Bioscience Co., Ltd.(South Korea)
  • Medytox Inc.(South Korea)
  • Croma-Pharma GmbH(Austria)

结论和建议

简介目录
Product Code: SQMIG35D2259

Skin Boosters Market size was valued at USD 1074.82 Billion in 2023 and is poised to grow from USD 1172.63 Billion in 2024 to USD 2353.75 Billion by 2032, growing at a CAGR of 9.1% during the forecast period (2025-2032).

The global skin booster market is on a robust growth trajectory, propelled by heightened consumer interest in skincare and aesthetic enhancements. These minimally invasive cosmetic injectables, primarily composed of hyaluronic acid, cater to the demand for non-surgical procedures that deliver natural results with minimal downtime. The surge in the aging population seeking to combat signs of aging, alongside a rising prevalence of skin conditions, is significantly driving market interest. Technological advancements have led to innovative formulations and superior delivery methods, enhancing treatment efficacy and safety. North America currently dominates the market, fueled by high consumer spending and a strong healthcare infrastructure, while the Asia-Pacific region is rapidly emerging due to increasing disposable income and changing beauty norms. Despite challenges like regulatory scrutiny and cost barriers, the skin booster market is expected to flourish, underpinned by ongoing innovation and an expanding client base.

Top-down and bottom-up approaches were used to estimate and validate the size of the Skin Boosters market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Skin Boosters Market Segmental Analysis

Global Skin Boosters Market is segmented by type, gender, end-use and region. Based on type, the market is segmented into mesotherapy and micro-needle. Based on gender, the market is segmented into female and male. Based on end-use, the market is segmented into dermatology clinics and medspa. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Skin Boosters Market

The Skin Boosters market is being driven by a growing desire among individuals to maintain a youthful and photogenic appearance. The COVID-19 pandemic and the rise of remote work have significantly increased the demand for wrinkle treatments as more people participate in virtual meetings and interviews, where a polished look is essential. Social media platforms, particularly Instagram and Facebook, amplify this trend, pushing individuals to enhance their skincare for better online representation. Additionally, the influence of online personalities who share lifestyle and beauty tips has further fueled this enthusiasm. Industry leaders are tapping into this phenomenon by collaborating with popular influencers to effectively market their skincare solutions.

Restraints in the Skin Boosters Market

The Skin Boosters market is hindered by several restraints, primarily revolving around high product costs and limited penetration among consumers. The expense associated with these treatments is a major challenge, as prices are shaped by the practitioner's expertise, the techniques used, and the overall complexity of the procedure. Additionally, since skin boosters offer temporary results, clients may find themselves needing further treatments down the line, adding to their financial commitment. This potential for ongoing costs can discourage many individuals from pursuing these options, leading them to prefer more affordable skincare alternatives that do not involve injections or invasive procedures.

Market Trends of the Skin Boosters Market

The Skin Boosters market is witnessing a significant trend driven by an increasing emphasis on preventive skincare among consumers. As individuals become more health-conscious and seek to maintain youthful, radiant skin, there's a growing adoption of skin boosters known for their ability to enhance hydration, improve elasticity, and combat early signs of aging. This proactive approach signifies a shift in consumer behavior, favoring treatments that not only address existing skin concerns but also serve as a long-term investment in skin health. As a result, the demand for innovative and effective skin booster products is rapidly expanding, shaping the future of skincare.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Landscape
  • Startup Analysis
  • Patent Analysis
  • Trade Analysis

Global Skin Boosters Market Size by Type & CAGR (2025-2032)

  • Market Overview
  • Mesotherapy
    • Hyaluronic Acid
    • Vitamins
    • Minerals
  • Micro-Needle
    • Dermal Fillers
    • Platelet-Rich Plasma (PRP)

Global Skin Boosters Market Size by Gender & CAGR (2025-2032)

  • Market Overview
  • Female
  • Male

Global Skin Boosters Market Size by End-Use & CAGR (2025-2032)

  • Market Overview
  • Dermatology Clinics
  • MedSpa

Global Skin Boosters Market Size & CAGR (2025-2032)

  • North America (Type, Gender, End-Use)
    • US
    • Canada
  • Europe (Type, Gender, End-Use)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, Gender, End-Use)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, Gender, End-Use)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, Gender, End-Use)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Galderma S.A. (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merz Aesthetics (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bloomage Biotechnology Corporation Limited (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teoxane Laboratories (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Filorga (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Professional Derma SA (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IBSA - Institute Biochemical SA (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Revance Therapeutics, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Suneva Medical, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Anika Therapeutics, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Prollenium Medical Technologies Inc. (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Revitrane (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Caregen Co., Ltd. (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hugel, Inc. (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Daewoong Pharmaceutical Co., Ltd. (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LG Chem Ltd. (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hyundai Bioscience Co., Ltd. (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medytox Inc. (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Croma-Pharma GmbH (Austria)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations